669066-91-5

Usage

Uses

Used in Chemical Research:
5-Bromo-3-Fluoropicolinic Acid is used as a research compound for [application reason] in the field of chemical research. It is employed to study its properties and potential applications in various scientific contexts.
Used in Pharmaceutical Industry:
5-Bromo-3-Fluoropicolinic Acid is used as an intermediate or building block for [application reason] in the development of pharmaceutical products. Its unique structure allows for the synthesis of new compounds with potential therapeutic applications.
Used in Material Science:
5-Bromo-3-Fluoropicolinic Acid is used as a component in the synthesis of advanced materials for [application reason] in material science. Its incorporation into materials can lead to improved properties, such as enhanced stability or reactivity.
Used in Agrochemical Industry:
5-Bromo-3-Fluoropicolinic Acid is used as a starting material or active ingredient for [application reason] in the development of agrochemical products. It may be involved in the synthesis of new pesticides or other agricultural chemicals.
Used in Environmental Applications:
5-Bromo-3-Fluoropicolinic Acid is used as a reagent or catalyst for [application reason] in environmental remediation processes. Its unique properties may contribute to the development of more efficient and effective solutions for environmental challenges.

InChI:InChI=1/C6H3BrFNO2/c7-3-1-4(8)5(6(10)11)9-2-3/h1-2H,(H,10,11)

Upstream product

• 886373-28-0 5-bromo-3-fluoropyridine-2-carbonitrile 
• 15862-34-7 5-bromo-3-nitro-2-pyridone 
• 573675-25-9 5-bromo-3-nitropyridine-2-carbonitrile 
• 15862-37-0 2,5-dibromo-3-nitro-pyridine 
• 669066-89-1 3-amino-5-bromopyridine-2-carboxylic acid amide 
• 669066-90-4 5-bromo-3-fluoro-pyridine-2-carboxylic acid amide 

Downstream Products

• 669066-93-7 5-bromo-3-fluoropyridine-2-carboxaldehyde 
• 943975-48-2 C₁₉H₂₂ClFN₂O₃S 
• 943975-64-2 C₁₅H₁₄ClFN₂O₂ 
• 943975-49-3 C₁₉H₂₁Cl₂FN₂O₃S 
• 761400-02-6 C₁₅H₁₃Cl₂FN₂O₂ 
• 943975-50-6 C₂₀H₂₄ClFN₂O₃S 
• 943975-65-3 C₁₆H₁₆ClFN₂O₂ 
• 943975-51-7 C₂₀H₂₃Cl₂FN₂O₃S 
• 943975-66-4 C₁₆H₁₅Cl₂FN₂O₂ 
• 943975-52-8 C₁₉H₂₁Cl₂FN₆OS 
• 943975-67-5 C₁₅H₁₃Cl₂FN₆ 
• 1211538-72-5 methyl 5-bromo-3-fluoro-pyridine-2-carboxylate 
• 1206968-92-4 (5-bromo-3-fluoropyridin-2-yl)methanol 

Relevant academic research and scientific papers

HETEROCYLIC COMPOUNDS

The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.

PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS

Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides and can be prepared in a manner known per se.

SMALL MOLECULE BRADYKININ B1 RECEPTOR ANTAGONISTS

Disclosed are compounds of formula (I) which are bradykinin B1 receptor (B1R) antagonists. These compounds are useful to treat diseases or relieve adverse symptoms associated with inflammation and pain. The invention encompasses novel compounds and acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases involving inflammation and pain.

Bradykinin B1 antagonists: Biphenyl SAR studies in the cyclopropanecarboxamide series

SAR study of the biphenyl region of cyclopropanecarboxamide derived bradykinin B1 antagonists was examined. Incorporation of a pyridine in place of the proximal phenyl ring and chlorination of the distal phenyl ring proved to be well tolerated

ALPHA-HYDROXY AMIDES AS BRADYKININ ANTAGONISTS OR INVERSE AGONISTS

α-Hydroxy amide derivatives of the general formula (I) are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway. R2a is selected from (1) a group selected from Ra. (2) (CH2)nNRbC(O)Ra. (3)(CH2)nNRbSO2Rd.(4)(CH2)nNRbCO2Ra.(5)(CH2)k-heterocycle optionally substituted with 1 to 3 groups independently selected from halogen.nitro, cyano.ORa.SRa.C1-4 alkyl and C1-3 haloakyl wherein said heterocycle is (a) a 5-membered heteroaromatic ring having a ring heteroatom selected from N.O and S. and optionally having up to 3 additional ring nitrogen atoms wherein said ring is optionally benzo-fused; or(b) a 6-membered heteromatic ring containing from 1 to 3 ring nitrogen atoms and N-oxydes thereof. Wherein said ring is optionally benzo-fused. (6)(CH2)kCO2Ra.and (7)(CH2)C(O)NRbRc. R2b is OH or a group selected from R2a; or R2a and R2b together with the carbon atom to which they are attached form a 3-to 7-membered carbocyclic ring optionally substituted with 1 to 4 groups independently selected from halogen. ORa. C1-4 alkyl and C1-4 haloalkyl;

AMINO CYCLOPROPANE CARBOXAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS

Compounds disclosed herein are bradykinin Bl antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.